Join to view full profile
909 Fulton St SEMinneapolis, MN 55455
Phone+1 612-273-8383
Dr. Okazaki is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of MinnesotaFellowship, Hematology and Medical Oncology, 1988 - 1991
UCLA-VA Greater Los AngelesResidency, Internal Medicine, 1985 - 1988
University of Hawaii, John A. Burns School of MedicineClass of 1985
Certifications & Licensure
CA State Medical License 1986 - Present
HI State Medical License 2003 - 2028
MN State Medical License 2024 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2011, 2013-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2011, 2013-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2011, 2013-2017
Clinical Trials
- Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting Start of enrollment: 2010 Dec 02
Publications & Presentations
PubMed
- Association ofAlterations with Outcomes AfterLu-PSMA-617 Treatment in Patients with Metastatic Castration-Resistant Prostate Cancer.Vikrant Mahajan, Lauren Yu, Lily Kollitz, Ella Boytim, Nicholas A Zorko
Journal of Nuclear Medicine. 2026-09-24 - 2 citationsPlasma extracellular vesicle proteomics nominates candidate biomarkers ofLu-PSMA-617 outcomes in metastatic prostate cancer patients.Ali T Arafa, Ella Boytim, Megan L Ludwig, Lily Kollitz, Tianzhong Yang
Cell Reports. Medicine. 2026-05-19 - 5 citationsCombined programmed cell death protein 1 and cytotoxic T-lymphocyte associated protein 4 blockade in an international cohort of patients with acral lentiginous melanoma.Erin McGillivray, Karam Ashouri, Eftychia Chatziioannou, Jesús Antonio Ocejo Gallegos, Jabra Zarka
The British Journal of Dermatology. 2025-01-24
Press Mentions
The Inspiring Lives of Devoted DoctorsMarch 29th, 2023
Local Philanthropists Donate $1M to Straub Medical CenterFebruary 7th, 2020
Health Care Heroes: Dr. Ian OkazakiNovember 2nd, 2016
Grant Support
- Characterization Of Mammalian Adp-RiboslytransferasesNational Heart, Lung, And Blood Institute1995
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
